Oxford Biomedica plc / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €482.89M +14.7% N/A N/A N/A N/A
    (estimated) €420.86M +36.7% €59.21M +139.0% 14.1% +0.060 pp €64.38M +178.9% 15.3% +0.078 pp
    (estimated) €307.96M +21.5% €24.77M -748.3% 8.0% +0.096 pp €23.09M -821.1% 7.5% +0.088 pp
    (estimated) €253.52M +34.2% -€3.82M -87.1% -1.5% +0.14 pp -€3.20M -75.2% -1.3% +0.056 pp
    (estimated) €188.97M +27.9% -€29.62M -40.2% -15.7% +0.18 pp -€12.93M -73.9% -6.8% +0.27 pp
    €147.79M +43.8% -€49.56M -72.6% -33.5% +1.4 pp -€49.49M +130.8% -33.5% -0.13 pp
    €102.74M -36.0% -€180.71M +248.7% -175.9% -1.4 pp -€21.44M -607.6% -20.9% -0.23 pp
    €160.63M -2.0% -€51.82M -337.5% -32.3% -0.46 pp €4.22M -89.5% 2.6% -0.22 pp
    €163.85M +62.8% €21.81M -404.4% 13.3% +0.20 pp €40.06M +111.9% 24.5% +0.057 pp
    €100.66M +36.9% -€7.17M -61.1% -7.1% +0.18 pp €18.90M -26.0% 18.8% -0.16 pp
    €73.51M -4.1% -€18.43M -313.0% -25.1% -0.36 pp €25.55M -3.3% 34.8% +0.0029 pp
    €76.62M +77.6% €8.65M -183.6% 11.3% +0.35 pp €26.41M +365.2% 34.5% +0.21 pp
    €43.13M +35.3% -€10.35M -45.8% -24.0% +0.36 pp €5.68M +266.0% 13.2% +0.083 pp
    €31.87M +74.6% -€19.09M +27.8% -59.9% +0.22 pp €1.55M -62.4% 4.9% -0.18 pp
    €18.25M +16.8% -€14.94M +50.3% -81.8% -0.18 pp €4.13M -890.8% 22.6% +0.26 pp
    €15.63M +153.4% -€9.94M -21.9% -63.6% +1.4 pp -€522.09K -95.5% -3.3% +1.8 pp
    €6.17M -30.7% -€12.73M +27.1% -206.4% -0.94 pp -€11.57M +7.6% -187.6% -0.67 pp
    €8.90M +0.5% -€10.02M -30.9% -112.6% +0.51 pp -€10.75M +0.3% -120.8% +0.0018 pp
    €8.86M -30.8% -€14.49M +22.8% -163.7% -0.71 pp -€10.71M -23.9% -120.9% -0.11 pp
    €12.80M -41.7% -€11.81M +192.7% -92.3% -0.74 pp -€14.08M -571.6% -110.0% -1.2 pp
    €21.94M +3.9% -€4.03M -65.0% -18.4% +0.36 pp €2.99M -115.1% 13.6% +1.1 pp
    €21.11M +154.8% -€11.52M -34.3% -54.6% +1.6 pp -€19.74M -434.0% -93.5% -1.6 pp
    €8.28M +849.9% -€17.54M -13.3% -211.8% +21 pp €5.91M -130.4% 71.4% +23 pp
    €872.06K -7.8% -€20.22M +94.0% -2,319.2% -12 pp -€19.46M +111.9% -2,231.1% -13 pp
    €945.50K +64.1% -€10.42M -13.2% -1,102.5% +9.8 pp -€9.18M -18.5% -971.0% +9.9 pp
    €576.02K +34.2% -€12.01M -2.6% -2,084.5% +7.9 pp -€11.27M +3.0% -1,956.4% +5.9 pp
    €429.15K +116.2% -€12.32M -7.9% -2,871.1% +39 pp -€10.94M +6.5% -2,548.7% +26 pp
    €198.51K -53.6% -€13.38M +39.0% -6,739.9% -45 pp -€10.27M +61.3% -5,171.7% -37 pp
    €428.00K -49.0% -€9.63M +67.7% -2,249.1% -16 pp -€6.36M +31.5% -1,486.9% -9.1 pp
    €839.93K +67.9% -€5.74M +19.4% -683.3% +2.8 pp -€4.84M +22.3% -576.0% +2.1 pp
    €500.29K +772.0% -€4.81M +13.8% -960.8% +64 pp -€3.95M +11.0% -790.4% +54 pp
    €57.37K +∞% -€4.22M +4,230.6% -7,362.0% -74 pp -€3.56M +14,013.6% -6,210.0% -62 pp
    €0.00 -€97.53K N/A -€25.24K N/A

    Notifications